Works by Farbstein, Motti

Results: 7

Namodenoson in Advanced Hepatocellular Carcinoma and Child–Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial.

Published in:

Cancers, 2021, v. 13, n. 2, p. 187, doi. 10.3390/cancers13020187

By:

Stemmer, Salomon M.;
Manojlovic, Nebojsa S.;
Marinca, Mihai Vasile;
Petrov, Petar;
Cherciu, Nelly;
Ganea, Doina;
Ciuleanu, Tudor Eliade;
Pusca, Ioana Adriana;
Beg, Muhammad Shaalan;
Purcell, William T.;
Croitoru, Adina-Emilia;
Ilieva, Rumyana Nedyalkova;
Natošević, Sladjana;
Nita, Amedeia Lavinir;
Kalev, Dimitar Nikolaev;
Harpaz, Zivit;
Farbstein, Motti;
Silverman, Michael H.;
Bristol, David;
Itzhak, Inbal

Publication type:

Article

Calcium supplements interact significantly with long-term diet while suppressing rectal epithelial proliferation of adenoma patients.

Published in:

Cancer (0008543X), 2001, v. 91, n. 4, p. 833, doi. 10.1002/1097-0142(20010215)91:4<833::AID-CNCR1071>3.0.CO;2-9

By:

Rozen, Paul;
Lubin, Flora;
Papo, Naomi;
Knaani, Judith;
Farbstein, Hanan;
Farbstein, Motti;
Zajicek, Gershom

Publication type:

Article

A long‑term complete response to namodenoson in liver cancer with Child‑Pugh B cirrhosis: A case report.

Published in:

2024

By:

Ciurescu, Ioana Adriana;
Lencioni, Riccardo;
Stemmer, Salomon M.;
Farbstein, Motti;
Harpaz, Zivit;
Bareket-Samish, Avital;
Silverman, Michael H.;
Fishman, Pnina

Publication type:

Case Study

Editorial: targeting aberrant hepatic inflammation for treatment of non‐alcoholic steatohepatitis—authors' reply.

Published in:

2022

By:

Safadi, Rifaat;
Braun, Marius;
Francis, Adi;
Milgrom, Yael;
Massarwa, Muhammad;
Hakimian, David;
Hazou, Wadi;
Issachar, Assaf;
Harpaz, Zivit;
Farbstein, Motti;
Itzhak, Inbal;
Lev‐Cohain, Naama;
Bareket‐Samish, Avital;
Silverman, Michael H.;
Fishman, Pnina

Publication type:

Editorial

Randomised clinical trial: A phase 2 double‐blind study of namodenoson in non‐alcoholic fatty liver disease and steatohepatitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 11, p. 1405, doi. 10.1111/apt.16664

By:

Safadi, Rifaat;
Braun, Marius;
Francis, Adi;
Milgrom, Yael;
Massarwa, Muhammad;
Hakimian, David;
Hazou, Wadi;
Issachar, Assaf;
Harpaz, Zivit;
Farbstein, Motti;
Itzhak, Inbal;
Lev‐Cohain, Naama;
Bareket‐Samish, Avital;
Silverman, Michael H.;
Fishman, Pnina

Publication type:

Article

CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study.

Published in:

2013

By:

Stemmer, Salomon M.;
Benjaminov, Ofer;
Medalia, Gal;
Ciuraru, Noab B.;
Silverman, Michael H.;
Bar-Yehuda, Sara;
Fishman, Sari;
Harpaz, Zivit;
Farbstein, Motti;
Cohen, Shira;
Patoka, Renana;
Singer, Barak;
Kerns, William D.;
Fishman, Pnina

Publication type:

Journal Article

CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study.

Published in:

Oncologist, 2013, v. 18, n. 1, p. 25, doi. 10.1634/theoncologist.2012-0211

By:

Stemmer, Salomon M.;
Benjaminov, Ofer;
Medalia, Gal;
Ciuraru, Noab B.;
Silverman, Michael H.;
Bar‐Yehuda, Sara;
Fishman, Sari;
Harpaz, Zivit;
Farbstein, Motti;
Cohen, Shira;
Patoka, Renana;
Singer, Barak;
Kerns, William D.;
Fishman, Pnina

Publication type:

Article